ACTIVATION OF PIK3CA IN A MODEL OF ENDOMETRIOSIS MAY SHED LIGHT ON THE PATHOGENESIS OF OVARIAN CLEAR CELL ADENOCARCINOMA

被引：0
|
作者：
Barbara, C. F. [1 ]
King, C. [1 ]
Jimenez-Linan, M. [2 ]
Brenton, J. [3 ]
Charnock-Jones, D. S. [1 ]
机构：
[1] Univ Cambridge, Cambridge, England
[2] Addenbrookes Hosp, Cambridge, England
[3] Cambridge Inst, Canc Res UK, Cambridge, England
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2019年 / 29卷
关键词：
D O I：
10.1136/ijgc-2019-ESGO.175
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P112
引用
收藏
页码：A127 / A128
页数：2
相关论文
共 50 条
  • [21] Molecular Alterations of PIK3CA in Uterine Carcinosarcoma, Clear Cell, and Serous Tumors
    Bashir, Shazia
    Jiang, Gaofeng
    Joshi, Ayesha
    Miller, Christopher, Jr.
    Matrai, Cathleen
    Yemelyanova, Anna
    Caputo, Thomas A.
    Holcomb, Kevin M.
    Ellenson, Lora Hedrick
    Gupta, Divya
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (07) : 1262 - 1267
  • [22] Stem Cell Model May Shed Light on Pathogenesis of Mental Illness
    Hampton, Tracy
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (13): : 1331 - 1331
  • [23] Clinical analysis and literature review of a case of ovarian clear cell carcinoma with PIK3CA gene mutation: A case report
    Farah, Abdulkarim Mohamed
    Gu, Shiyu
    Jia, Yan
    [J]. MEDICINE, 2022, 101 (37) : E30666
  • [24] Ovarian clear cell carcinoma with an immature teratoma component showing ARID1A deficiency and an identical PIK3CA mutation
    Kihara, Atsushi
    Iizuka, Toshihiko
    Endo, Shinichi
    Horie, Koji
    Kanda, Hiroaki
    Niki, Toshiro
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (09) : 3401 - 3407
  • [25] PIK3CA hotspot mutations and cyclooxygenase-2 expression in ovarian clear cell carcinomas: a close association with stromal features
    Kato, Noriko
    Sato, Yuka
    Kamataki, Akihisa
    Fukase, Masayuki
    Uchigasaki, Shinya
    Kurose, Akira
    [J]. HUMAN PATHOLOGY, 2019, 86 : 32 - 37
  • [26] An oncogenic, somatic mutation of PIK3CA identified in 2 primary malignancies: clear cell renal cell carcinoma and prostate adenocarcinoma in the same patient
    Marek-Bukowiec, Karolina
    Ratajczyk, Krzysztof
    Rogala, Joanna
    Kosinski, Mariusz
    Kowal, Pawel
    Witkiewicz, Wojciech
    [J]. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (01): : 93 - 95
  • [27] A Rare Pathological Phenotype of Endometrioid Serous and Clear-Cell Ovarian Cancer with PIK3CA Mutations in Relation to The Excellent Response of Alpelisib
    Bayram, Ertugrul
    Khatib, Ghanim
    Guney, Burak
    Kilicbagir, Emine
    Gulec, Huru Rabia
    Boga, Ibrahim
    Paydas, Semra
    [J]. GENES, 2023, 14 (08)
  • [28] Copy number gain of PTK2 and PIK3CA mutations are common genetic alterations in ovarian clear cell carcinoma.
    Yoon, Heejei
    Choi, Yoon-La
    Song, Ji-Young
    Do, Ingu
    Kang, So Young
    Ko, Young-Hyeh
    Song, Sangyong
    Kim, Byong-Gie
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [29] Identification and Validation of PIK3CA as a Marker Associated with Prognosis and Immune Infiltration in Renal Clear Cell Carcinoma
    Li, Ya
    Wang, Chong
    Gao, Yang
    Zhou, Liang
    [J]. JOURNAL OF ONCOLOGY, 2021, 2021
  • [30] Targeted sequencing of a specific gene panel detects a high frequency of ARID1A and PIK3CA mutations in ovarian clear cell carcinoma
    Su, Yu-Fa
    Tsai, Eing-Mei
    Chen, Chih-Chieh
    Wu, Chun-Chieh
    Er, Tze-Kiong
    [J]. CLINICA CHIMICA ACTA, 2019, 494 : 1 - 7
12345